Marchesa P, Fazio V W, Oliart S, Goldblum J R, Lavery I C, Milsom J W
Department of Colorectal Surgery, Cleveland Clinic Foundation, Ohio 44195, USA.
Ann Surg Oncol. 1997 Sep;4(6):475-80. doi: 10.1007/BF02303671.
Perianal Paget's disease (PPD) is a rare intraepithelial adenocarcinoma with a significant rate of recurrence after treatment and high risk of progression to an invasive cancer.
Fourteen patients with a mean follow-up longer than 5 years were studied to determine the outcome after surgical treatment. The immunohistochemical accumulation of p53 protein also was assessed in tissue specimens to evaluate its prognostic role in patients with PPD.
Four patients were excluded because of progression to invasive malignancy at the time of diagnosis. Two patients underwent local excision (LE) with macroscopic clearance of the surgical margins; the remaining eight patients underwent wide local excision (WLE), i.e., > 1 cm microscopic clearance of the surgical margins. The actuarial 8-year recurrence rate for patients treated with LE and WLE was 100% and 50% (SE = 17.7), respectively. Progression to invasive carcinoma occurred after a median time of 56 months (range 23-72) in two patients treated with LE and in one of eight patients treated with WLE. All four patients with recurrence after WLE were successfully treated (no further recurrence) with a second WLE. Actuarial 8-year survival was 0% in the LE group and 40% (SE = 21.9) in the WLE group. There was no p53 protein accumulation in any of the ten patients with PPD.
Survival of patients with PPD treated by WLE was higher than that for those treated with LE. Thus, wide local excision is recommended over limited local excision as a preferred treatment for PPD. Follow-up longer than 5 years seems to be indicated because of the risk of late progression to invasive cancer. When PPD does recur, a second WLE may be curative. The absence of accumulated p53 protein suggests that this marker may not have a prognostic role in PPD.
肛周佩吉特病(PPD)是一种罕见的上皮内腺癌,治疗后复发率高,进展为浸润性癌的风险也高。
对14例平均随访时间超过5年的患者进行研究,以确定手术治疗后的结果。还对组织标本中p53蛋白的免疫组化积聚情况进行评估,以评价其在PPD患者中的预后作用。
4例患者因诊断时进展为浸润性恶性肿瘤而被排除。2例患者接受了局部切除(LE),手术切缘肉眼清除;其余8例患者接受了广泛局部切除(WLE),即手术切缘显微镜下清除>1cm。接受LE和WLE治疗的患者8年精算复发率分别为100%和50%(标准误=17.7)。接受LE治疗的2例患者和接受WLE治疗的8例患者中的1例在中位时间56个月(范围23 - 72个月)后进展为浸润性癌。WLE后复发的所有4例患者均通过再次WLE成功治疗(无进一步复发)。LE组8年精算生存率为0%,WLE组为40%(标准误=21.9)。10例PPD患者中均未检测到p53蛋白积聚。
WLE治疗的PPD患者生存率高于LE治疗的患者。因此,推荐广泛局部切除而非有限局部切除作为PPD的首选治疗方法。由于存在晚期进展为浸润性癌的风险,似乎需要进行超过5年的随访。当PPD复发时,再次WLE可能治愈。p53蛋白未积聚表明该标志物可能在PPD中无预后作用。